Mcr-1–positive colistin-resistant escherichia coli in traveler returning to Canada from China

Emerging Infectious Diseases

Volumn 22, Issue 9, 2016, Pages 1673-1675

  Payne, Michael ^a   Croxen, Matthew A ^c   Lee, Tracy D ^c   Mayson, Brian ^a   Champagne, Sylvie ^a   Leung, Victor ^a   Bariso, Sherri ^a,b   Hoang, Linda ^b,c   Lowe, Christopher ^a,b  

^a Providence Health Care   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFAZOLIN; CEFTRIAXONE; CIPROFLOXACIN; COLISTIN; ERTAPENEM; GENTAMICIN; MEROPENEM; NITROFURANTOIN; PIPERACILLIN; SULFAMETHOXAZOLE; TAZOBACTAM; TOBRAMYCIN; TRIMETHOPRIM; ANTIINFECTIVE AGENT; ESCHERICHIA COLI PROTEIN; MCR-1 PROTEIN, E COLI;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; CANADA; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CASE REPORT; CHINA; ESCHERICHIA COLI INFECTION; FEVER; GENE; GENE SEQUENCE; HOSPITAL DISCHARGE; HUMAN; LETTER; LEUKOCYTOSIS; MALE; MCR 1 GENE; MIDDLE AGED; MINIMUM INHIBITORY CONCENTRATION; REAL TIME POLYMERASE CHAIN REACTION; TRANSURETHRAL RESECTION; TRAVEL; URINARY CATHETER; COMMUNICABLE DISEASE; DRUG EFFECTS; ESCHERICHIA COLI; GENETICS; MICROBIOLOGY; PLASMID; POLYMERASE CHAIN REACTION; TRANSMISSION;

ANTI-BACTERIAL AGENTS; CANADA; CHINA; COLISTIN; COMMUNICABLE DISEASES, IMPORTED; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; HUMANS; MALE; MIDDLE AGED; PLASMIDS; POLYMERASE CHAIN REACTION; TRAVEL;

EID: 84988432360     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2209.160177     Document Type: Letter

References (10)

1. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 6.0. The Committee; 2016. http://aurosan.de/wp-content/ uploads/2015/05/v_6.0_Breakpoint_table.pdf
2. Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: A microbiological and molecular biological study. Lancet Infect Dis. 2016;16:161–8.
3. Ingle D, Valcanis M, Kuzevski A, Tauschek M, Inouye M, Stinear T, et al. In silico serotyping of E. coli from short read data identifies limited novel O-loci but extensive diversity of O:H serotype combinations within and between pathogenic lineages. Microbial Genomics. 2016.
4. Carattoli A, Zankari E, García-Fernández A, Voldby Larsen M, Lund O, Villa L, et al. In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing. Antimicrob Agents Chemother. 2014;58:3895–903. http://dx.doi.org/10.1128/AAC.02412-14
5. Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS, et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol. 2012;19:455–77. http://dx.doi.org/10.1089/cmb.2012.0021
6. Alikhan NF, Petty NK, Ben Zakour NL, Beatson SA. BLAST ring image generator (BRIG): simple prokaryote genome comparisons. BMC Genomics. 2011;12:402.
7. Skov RL, Monnet DL. Plasmid-mediated colistin resistance (mcr-1 gene): three months later, the story unfolds. Euro Surveill. 2016;21:30155 http://dx.doi.org/10.2807/1560-7917. ES.2016.21.9.30155.
8. Hindler JA, Humphries RM. Colistin MIC variability by method for contemporary clinical isolates of multidrug-resistant Gram-negative bacilli. J Clin Microbiol. 2013;51:1678–84 http://dx.doi.org/10.1128/JCM.03385-12.
9. Mulvey MR, Mataseje LF, Robertson J, Nash JH, Boerlin P, Toye B, et al. Dissemination of the mcr-1 colistin resistance gene. Lancet Infect Dis. 2016;16:289–90 http://dx.doi.org/10.1016/ S1473-3099(16)00067-0.
10. Poirel L, Kieffer N, Liassine N, Thanh D, Nordmann P. Plasmid-mediated carbapenem and colistin resistance in a clinical isolate of Escherichia coli. Lancet Infect Dis. 2016;16:281 http://dx.doi.org/10.1016/S1473-3099(16)00006-2.